[1] Tonetti MS, Chapple IL; Working Group 3 of Seventh European Workshop on Periodontology. Biological approaches to the development of novelperiodontal therapies-consensus of the Seventh European Workshop on Periodontology[J]. J Clin Periodontol, 2011, 38 (Suppl 11): 114-118. [2] Gokhale SR, Padhye AM. Future prospects of systemic host modulatory agents in periodontal therapy[J]. Br Dent J, 2013, 214(9):467-471. [3] Kayal RA. The role of osteoimmunology in periodontal disease [J]. Biomed Res Int, 2013, 2013: 639368. [4] Kim SJ, Diamond B. Modulation of tolerogenic dendritic cells and autoimmunity [J]. Semin Cell Dev Biol, 2015, 41(1):49-58. [5] Dentino A, Lee S, Mailhot J, et al. Principles of periodontology [J]. Periodontol 2000, 2013, 61(1):16-53. [6] Offenbacker S, Williams RC,Jeffcoat MK, et al. Effects of NSAIDs on beagle crevicular cyclooxigenase metabolites and periodontal bone loss[J]. J Periodontal Res, 1992, 27(3): 207-213. [7] Jeffcoat MK, Williams RC, Reddy MS, et al. Flurbiprofen treatment of human periodontitis: effect on alveolar bone height and metabolism [J]. J Periodontal Res, 1988, 23(6): 381-385. [8] 朱治宇, 刘国勤. 慢性牙周炎治疗前后患牙龈沟液中IL-8和TNF-α水平变化比较[J]. 细胞与分子免疫学杂志, 2010, 26(11): 1111-1112. [9] Gokul K. Estimation of the level of tumor necrosis factor-α in gingival crevicular fluid and serum in periodontal health and disease: a biochemical study [J]. Indian J Dent Res, 2012, 23(3): 348-352. [10] 刘继刚, 刘昊. 慢性牙周炎患者龈沟液中MIP-1α和TNF-α的变化 [J]. 牙体牙髓牙周病学杂志, 2016, 26(8): 495-497. [11] Boyce BF. Advances in the regulation of osteoclasts and osteoclast functions [J]. J Dent Res, 2013, 92(10): 860-867. [12] Belibasakis GN, Bostanci N. The RANKL-OPG system in clinical periodontology [J]. J Clin Periodontol, 2012, 39(3): 239-48. [13] Ozgören O, Develioglu H, Güncü G, et al. The adjunctive effect of tenoxicam during non-surgical periodontal treatment on clinical parameters and gingival crevicular fluid levels of MMP-8 and TNF-α in patients with chronic periodontitis - randomized, double-blind clinical trial [J]. Adv Clin Exp Med, 2014, 23(4): 559-565. [14] 侯振伟, 白鹤翔, 张风华. 布洛芬缓释凝胶治疗慢性牙周炎的临床研究 [J]. 实用口腔医学杂志, 2008, 24(5): 741-743. [15] Sekino S, Ramberg P, Lindhe J. The effect of systemic administration of ibuprofen in the experimental gingivitis model [J]. J Clin Periodontol, 2005, 32(2): 182-187. [16] Shiloah J, Bland PS, Scarbecz M, et al. The effect of long-term aspirin intake on the outcome of non-surgical periodontal therapy in smokers: a double-blind, randomized pilot study [J]. J Periodontal Res, 2014, 49(1): 102-109. [17] Srivastava M, Kohli K, Ali M. Formulation development of novel in situ nanoemulgel (NEG) of ketoprofen for the treatment of periodontitis [J]. Drug Deliv, 2016, 23(1): 154-166. [18] Srivastava M, Neupane YR, Kumar P, et al. Nanoemulgel (NEG) of Ketoprofen with eugenol as oil phase for the treatment of ligature-induced experimental periodontitis in Wistar rats [J]. Drug Deliv, 2016, 23(7): 2228-2234. [19] Naqvi AZ, Hasturk H, Mu L, et al. Docosahexaenoic acid and periodontitis in adults: a randomized controlled trial[J]. J Dent Res, 2014, 93(8): 767-773. [20] Elwakeel NM, Hazaa HH. Effect of omega 3 fatty acids plus low-dose aspirin on both clinical and biochemical profiles of patients with chronic periodontitis and type 2 diabetes: a randomized double blind placebo-controlled study[J]. J Periodontal Res, 2015, 50(6): 721-729. |